Amgen (AMGN) Revenue — Quarter Ended Sep 30, 2025
Revenue rose in the current quarter. The increase continued a pattern of sequential growth and was larger relative to the same period a year earlier.
Key takeaway
Quarter ended Sep 30, 2025 · FY2025 Q3
Revenue rose in the current quarter. The increase continued a pattern of sequential growth and was larger relative to the same period a year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$9.6B
Revenue reported for this quarter.
Quarter-over-quarter
+4.1%
Change from the immediately preceding quarter.
Year-over-year
+12.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$36B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2024 | $9.1B | +10.9% |
| Mar 31, 2025 | $8.1B | +9.4% |
| Jun 30, 2025 | $9.2B | +9.4% |
| Sep 30, 2025 | $9.6B | +12.4% |
Revenue performance
The reported revenue increased compared with both the immediately preceding quarter and the same quarter one year prior. The year-over-year gain was more pronounced than the sequential gain.
Quarterly comparison
Revenue was higher than the prior quarter, marking a continuation of the upward trajectory observed over the recent periods. Compared with the same quarter a year earlier, revenue also showed an increase, with the year-over-year rate exceeding the sequential rate.
What to watch
The filing notes discussions of tariffs and trade protection measures, which could affect future revenue performance.